Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™

Clinical trial NCT01358825 · COMPLETED

Trial details

NCT number: NCT01358825
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Tetanus Poliomyelitis Haemophilus Influenzae Type b Acellular Pertussis Diphtheria Hepatitis B Diphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Start date: 2011-05-30
Primary completion: 2011-07-15
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.